Lenvatinib Plus PD-1 Blockade in Refractory or Unresectable Biliary Tract Carcinoma: Insights from Real-World Evidences
Year: 2019
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3414434
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3161561893
